Reckitt Benckiser Group PLC Directorate Change (0065J)
17 Dezember 2020 - 11:45AM
UK Regulatory
TIDMRB.
RNS Number : 0065J
Reckitt Benckiser Group PLC
17 December 2020
RB announces appointment of Olivier Bohuon as non-executive
director
December 17, 2020, Slough UK - Reckitt Benckiser Group plc today
announces the appointment of Olivier Bohuon to the Board as a
non-executive director, effective January 1(st) , 2021. He will
also join the Remuneration Committee on the same date.
Mr Bohuon was CEO of FTSE 100 medical devices company Smith
& Nephew from 2011 to 2018. Prior to that role he served as CEO
of healthcare, cosmetology and pharmaceutical company Laboratoires
Pierre Fabre from 2010-2011. Before that he worked for Abbott
Laboratories from 2003 to 2010, rising to corporate executive vice
president and president of the pharmaceutical products division. Mr
Bohuon previously worked at GlaxoSmithKline plc for a number of
years in positions of increasing seniority.
Mr Bohuon is a member of the supervisory board of Virbac SA, is
Chairman of the Board of Directors of Leo Pharma in Denmark and
serves on the Board of Takeda Pharmaceuticals in Japan. He also
served on the Board of Smiths Industries from July 2018 to November
2020.
Mr Bohuon is a member of the National Pharmacy Academy and the
Academy of Technologies. He became a Knight of the Legion of Honour
in 2007. He has a doctorate in pharmacy from University of
Paris-Sud and MBA from HEC Paris.
Commenting on the appointment, Chris Sinclair, Chairman of the
Board said:
"I am delighted that Olivier has agreed to join the Board. He is
a successful leader, with many years of experience as CEO of a
large global company. Olivier has deep experience in healthcare
products and markets and will bring great insight to the Board and
we welcome his appointment."
The Company confirms that there is no further information to be
disclosed under the requirements of Listing Rule 9.6.13R in
relation to Olivier Bohuon's appointment.
About RB
RB* is driven by its purpose to protect, heal and nurture in a
relentless pursuit of a cleaner, healthier world. We fight to make
access to the highest-quality hygiene, wellness and nourishment a
right, not a privilege, for everyone.
RB is proud to have a stable of trusted household brands found
in households in more than 190 countries. These include Enfamil,
Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl,
Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein,
Finish, Vanish, Calgon, Woolite, Air Wick and more. 20 million RB
products a day are bought by consumers globally.
RB's passion to put consumers and people first, to seek out new
opportunities, to strive for excellence in all that we do, and to
build shared success with all our partners, while doing the right
thing, always is what guides the work of our 40,000+ diverse and
talented colleagues worldwide. For more information visit
www.rb.com
Reckitt Benckiser Group plc's LEI code is
5493003JFSMOJG48V108
*RB is the trading name of the Reckitt Benckiser group of
companies
For further information, please
contact:
Reckitt Benckiser
Patty O'Hayer, James Fearnley-Marr +44 (0)1753 217800
Finsbury
Faeth Birch +44 (0)7768 943171
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAGPGWWPUPUGUM
(END) Dow Jones Newswires
December 17, 2020 05:45 ET (10:45 GMT)
Reckitt Benckiser (LSE:RKT)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Reckitt Benckiser (LSE:RKT)
Historical Stock Chart
Von Mär 2023 bis Mär 2024